ABBNY
Abb LtdCompany with tickers: ABLZF, ABBNY
CIK
1091587
CUSIP
000375204
Shares Outstanding
1,815,147,741
13F Activity (30d)
22 filings
16 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $32,235,000,000 | USD | 2023-12-31 | 20-F | 2024-02-23 |
| Revenue (ASC 606) | $32,235,000,000 | USD | 2023-12-31 | 20-F | 2024-02-23 |
| Cost of Revenue | $21,021,000,000 | USD | 2023-12-31 | 20-F | 2024-02-23 |
| Gross Profit | $11,214,000,000 | USD | 2023-12-31 | 20-F | 2024-02-23 |
| Operating Expenses | — | ||||
| Research & Development | $1,317,000,000 | USD | 2023-12-31 | 20-F | 2024-02-23 |
| Operating Income | $4,871,000,000 | USD | 2023-12-31 | 20-F | 2024-02-23 |
| Net Income | — | ||||
| EPS (Basic) | $2.02 | USD/shares | 2023-12-31 | 20-F | 2024-02-23 |
| EPS (Diluted) | $2.01 | USD/shares | 2023-12-31 | 20-F | 2024-02-23 |